Ionis Pharmaceuticals - 株価

IONS

40.88

毎日の変更:

-3.71%

毎年:

-20.44%

価格 日 年
Astellas Pharma 1,638.00 1.50 0.09% -4.93%
Agios Pharmaceuticals 52.24 -0.53 -1.00% 31.32%
Alnylam Pharmaceuticals 135.03 -3.20 -2.32% 13.46%
Arena Pharmaceuticals 64.76 -1.53 -2.31% 35.82%
Arrowhead Research 62.78 0.63 1.01% 80.14%
BioCryst Pharmaceuticals 9.50 -0.71 -6.95% 304.26%
Bluebird Bio 27.98 -0.18 -0.64% -39.05%
BioMarin Pharmaceutical 77.11 0.04 0.05% -7.09%
Dicerna Pharmaceuticals 26.18 0.09 0.35% 38.52%
Esperion Therapeutics 26.02 -0.93 -3.45% -27.26%
Exelixis 23.03 -0.09 -0.39% 29.53%
GW Pharmaceuticals 217.77 -0.16 -0.07% 123.24%
Halozyme Therapeutics 42.95 0.18 0.42% 138.35%
Intercept Pharmaceuticals 22.14 -0.03 -0.14% -68.08%
Moderna Inc 139.25 -1.60 -1.14% 323.25%
Mirati Therapeutics 159.68 -10.49 -6.16% 94.73%
Neurocrine Biosciences 92.79 -0.56 -0.60% -3.29%
Nektar Therapeutics 18.68 0.05 0.27% 0.11%
Novartis 80.68 -0.22 -0.27% -2.56%
Omeros 16.93 -1.30 -7.13% 24.85%
Pfizer 36.97 0.37 1.01% 5.21%
PTC Therapeutics 47.13 -0.47 -0.99% 4.92%
Ultragenyx Pharmaceutical 100.53 -2.95 -2.85% 88.86%
Regeneron Pharmaceuticals 472.80 -2.37 -0.50% -8.55%
Roche Holding 306.80 -2.85 -0.92% -2.59%
Sarepta Therapeutics 69.38 -1.16 -1.64% -37.84%
Vertex Pharmaceuticals 213.60 0.25 0.12% -15.33%


IONS:US
資産
現金と同等
売上原価
流動資産
流動負債
負債
EBIT
EBITDA
株当たりのEPS利益
自己資本および準備金
売上総利益
債務の支払利息
借入資本
時価総額
当期純利益
営業経費
営業利益
普通株資本
収益へのPE価格
税引前利益
販売収入
販売および管理費
株式
貿易債権者
貿易債務者